Healthcare Roundup – States go after generic drugmakers for alleged price-fixing, Lilly’s COVID-19 treatment maybe available as soon as September Jun 10, 2020 Life Science
CANbridge Pharmaceuticals Enters Into Rare Disease Gene Therapy Research Agreement With UMass Medical School Jun 9, 2020 Life Science
Healthcare Roundup – Dynavax advancing hepatitis B vaccine, Aytu announces performance stats on COVID-19 blood test Jun 9, 2020 Life Science
Aleafia Health to Commence Cultivation in Entire 160,000 sq. ft. Niagara Greenhouse Facility Jun 9, 2020 Life Science
Avalon GloboCare Announces Diagnostic Platform for Point-of-Care Rapid Detection of COVID-19 (SARS-CoV-2) and Its Clinically Relevant Mutation Strains Jun 8, 2020 Life Science
Healthcare Roundup – Asymptomatic spread of COVID-19 rare, Gilead files remdesivir application in Europe Jun 8, 2020 Life Science
Healthcare Roundup – Sorrento up 15% on encouraging COVIDTRAP data, Novavax scores defense funding for COVID-19 vaccine Jun 5, 2020 Life Science
Healthcare Roundup – Inovio to begin Phase 1/2 trial of COVID-19 DNA vaccine, Roche’s severe COVID-19 test scores FDA approval Jun 4, 2020 Life Science
Healthcare Roundup – Novavax secures source for COVID-19 vaccine adjuvant, Pfizer announces publication of successful abrocitinib study in atopic dermatitis Jun 3, 2020 Life Science
DIAGNOS Announces Signing of Strategic Partnership Agreement with Labtician Ophthalmics, Leading Global Ophthalmology Product and Equipment Supplier Jun 3, 2020 Life Science
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors Jun 3, 2020 Life Science
Healthcare Roundup – FDA OKs emergency use of Philips monitors for COVID-19 use, AgeX Therapeutics +12% on ESI 053 deal for COVID-19 Jun 2, 2020 Life Science
Healthcare Roundup – FDA OKs emergency use of Siemens COVID-19 blood test, Short regimen of Gilead’s remdesivir beats standard-of-care in COVID-19 study Jun 1, 2020 Life Science
Healthcare Roundup – Gilead not quite there with remdesivir nod in Europe, Chi-Med’s NDA for savolitinib accepted in China May 30, 2020 Life Science
